← Open Payments lookup

DEAN WHITLEY: Open Payments

NPI 1093721037 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,813 in 69 payments from 19 companies in 2025. Trend: 2023 $2,044 · 2024 $1,777 · 2025 $1,813

Food & beverage: $1,813
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$295
E.R. Squibb & Sons, L.L.C.6$217
Alnylam Pharmaceuticals Inc.7$202
Novartis Pharmaceuticals Corporation10$177
Boston Scientific Corporation3$168
Merck Sharp & Dohme LLC5$115
Novo Nordisk Inc4$88
ABIOMED3$74
BridgeBio Pharma, Inc.3$68
Bayer Healthcare Pharmaceuticals Inc.3$67

Products named: WAINUA, AMVUTTRA, CAMZYOS, LEQVIO, WATCHMAN Access System, VERQUVO, ELIQUIS, Wegovy.

Industry payments across MS — which companies pay providers there.